Advertisement

Agents and Actions

, Volume 12, Issue 1–2, pp 221–224 | Cite as

The run-in period in trial design: A comparison of two non-steroidal anti-inflammatory agents in psoriatic arthropathy

  • P. A. Leatham
  • H. A. Bird
  • V. Wright
  • P. D. Fowler
Immunosupression and Inflammation

Abstract

Psoriatic arthropathy is a relatively uncommon arthritis that exists in a wide variety of clinical forms. These two features of the disease cause problems in the design of clinical trials.

In a comparison of two non-steroidal anti-inflammatory agents in this condition we attempted to overcome the difficulties by using a run-in period during which the dosage of one of the trial drugs was adjusted to suit the individual patient. After two weeks on indomethacin (75 mg or 150 mg/day) patients were allocated to four-week periods of indomethacin in the chosen dosage or diclofenac (75 mg or 150 mg/day) in a double-blind randomized crossover trial that used double dummy packaging.

Of the 35 patients that entered the study, 19 completed both study groups. No significant differences were observed between the clinical improvements due to both drugs during the course of the study. In general more side-effects were seen during indomethacin treatment, though the study design precluded exact comparison. In a study biased against diclofenac, patient preference was 9/19 for indomethacin, 4/19 for diclofenac and 7/19 expressing no choice.

Advantages and disadvantages of the study design are discussed.

Keywords

Arthritis Indomethacin Patient Preference Arthropathy Crossover Trial 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    O.L. Meyers, O.P. Quantock, P.G. Joubert, D.F. du P. Louw, D.F. Marais, W.A. McDonald Scott andF.O. Muller,A multi-centre trial of Voltaren in the treatment of rheumatoid arthritis, S. Afr. Med. J.48, 2013–2017 (1974).PubMedGoogle Scholar
  2. [2]
    T. Durrigl, M. Vitaus, L. Pucar andM. Miko,Diclofenac sodium (Voltaren): Results of a multicentre comparative trial in adult-onset rheumatoid arthritis, J. Int. Med. Res.3, 139–144 (1975).PubMedGoogle Scholar
  3. [3]
    M.S. Doreen, P.L. Boardman, P.D. Fowler andP.H. Poole,Diclofenac (Voltarol) in rheumatoid arthritis: A report of a double-blind trial, Rheum. Rehab.17, 95–102 (1978).Google Scholar
  4. [4]
    N. Cardoe andP.D. Fowler,Diclofenac sodium (Voltarol): A double-blind comparative study with ibuprofen in patients with rheumatoid arthritis, Rheum Rehab. Suppl.2, 89–97 (1979).Google Scholar
  5. [5]
    P.H. Joubert, A.R. Kushlick, W.G. McNeil, F.O. Muller andE.S.C. Sheard,South African multicentre trial with Voltaren in osteoarthritis of the knee, S. Afr. Med. J.48, 1973–1978 (1974).PubMedGoogle Scholar
  6. [6]
    F.A. Rossi andL. Baroni,A double-blind comparison between diclofenac sodium and ibuprofen in osteoarthritis, J. Int. Med. Res.3, 267–274 (1975).Google Scholar
  7. [7]
    C.G. Barnes, H. Berry, M.E. Carter, W.W. Downie, P.D. Fowler, J.M.H. Moll, J.D. Perry, M.S. Sawaf andV. Wright,Diclofenac sodium (Voltarol) and indomethacin: A multi-centre comparative study in rheumatoid arthritis and osteoarthritis, Rheum. Rehab. Suppl. 2, 135–143 (1979).Google Scholar
  8. [8]
    K. Reinberger,Efficacy and tolerance of Voltaren and indomethacin in patients with ankylosing spondylitis, Therapiewoche26, 2916–2920 (1976).Google Scholar
  9. [9]
    M.E.T. Roberts, V. Wright, A.G.S. Hill andA.C. Mehra,Psoriatic arthritis — Follow-up study, Ann. Rheum. Dis.35, 206–212 (1976).PubMedGoogle Scholar
  10. [10]
    M. Zbojanova, K. Trnavsky andF. Ulcek,Indocid in the treatment of psoriatic arthritis, CESK Dermatol.49, 129–132 (1974).PubMedGoogle Scholar
  11. [11]
    N.O. Rothermich,An extended study of indomethacin II. Clin. Ther. J.A.M.A.195, 1102–1106 (1966).Google Scholar
  12. [12]
    W.M. O'Brien,Indomethacin: A survey of clinical trials, Clin. Pharm. Ther.9, 94–107 (1968).Google Scholar
  13. [13]
    D.M. Ritchie, J.A. Boyle, J.M. McInnes, M.K. Jasani, T.G. Dalakos, P. Grieveson andW.W. Buchanan,Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q. J. Med.37, 393–406 (1968).PubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag 1982

Authors and Affiliations

  • P. A. Leatham
    • 1
    • 2
  • H. A. Bird
    • 1
    • 2
  • V. Wright
    • 1
    • 2
  • P. D. Fowler
    • 3
  1. 1.Clinical Pharmacology UnitRoyal Bath HospitalHarrogateUK
  2. 2.Rheumatism Research Unit, Department of MedicineGeneral Infirmary at LeedsLeedsUK
  3. 3.Staffordshire Rheumatology ClinicStoke-on-TrentUK

Personalised recommendations